RT Journal Article
SR Electronic
T1 Cognitive impairment and functional change in COVID-19 patients undergoing inpatient rehabilitation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.15.21253637
DO 10.1101/2021.03.15.21253637
A1 Patel, Ruchi
A1 Savrides, Irene
A1 Cahalan, Christine
A1 Doulatani, Gargi
A1 O’Dell, Michael W.
A1 Toglia, Joan
A1 Jaywant, Abhishek
YR 2021
UL http://medrxiv.org/content/early/2021/05/13/2021.03.15.21253637.abstract
AB Cognitive impairment is increasingly recognized as a sequela of COVID-19. It is unknown how cognition changes and relates to functional gain during inpatient rehabilitation. We administered the Montreal Cognitive Assessment (MoCA) at admission to 77 patients undergoing inpatient rehabilitation for COVID-19 in a large U.S. academic medical center. 45 patients were administered the MoCA at discharge. Functional gain was assessed by change in the Quality Indicator for Self-Care (QI-SC). In the full sample, 80.5% of patients exhibited cognitive impairment on admission, which was associated with prior delirium. Among 45 patients with retest data, there were significant improvements in MoCA and QI-SC. QI-SC score gain was higher in patients who made clinically meaningful changes on the MoCA, an association that persisted after accounting for age and delirium history. Cognitive impairment is frequent among COVID-19 patients, but improves over time and is associated with functional gain during inpatient rehabilitation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/A (This is a retrospective electronic medical record review study)Funding StatementThe authors received no specific funding to complete this project. AJ receives salary support from a career development award from the National Institutes of Health via a subaward from Georgetown University (Grant Number: 1K12HD093427-04).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data were extracted from retrospective chart reviews under approval of the Weill Cornell Medicine Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for this manuscript are not available.